DDL logo
Menu
  • The Aerosol Society logo
DDL logo
  • DDL2023
    • Call for Papers
    • Sponsor and Exhibit
    • New Researcher Network
    • Conference Logistics
    • Media Partners
  • Archive
    • Conference Papers Archive
    • DDL2022
      • APS Workshop
      • Conference Papers
      • DDL2022 Programme
      • DDL2022 Speakers
      • DDL2022 Sponsors
      • DDL2022 Photo Album
    • DDL2021
      • Conference Papers
      • DDL2021 Programme
      • DDL2021 Speakers
      • DDL2021 Sponsors
    • DDL2020
      • Conference Papers
      • Speakers and Lecture Recordings
      • Sponsors
    • DDL2019
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2019 Photo Album
    • DDL2018
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2018 Photo Album
    • DDL2017
      • Conference Papers
      • Speakers
      • Sponsors
      • DDL2017 Photo Album
    • DDL2016
      • Conference Papers
      • Speakers
      • Sponsors
    • DDL2015
      • Conference Papers
    • Previous Years
  • DDL Annual Lecture
  • Awards & Grants
    • DDL Career Development Grant
    • The DDL Emerging Scientist Award
    • The Pat Burnell Young Investigator Award
    • Aerosol Society Awards
  • About
    • Gallery
    • History
    • DDL Charter
    • Committee
    • Scientific Advisors
  • Associated Events
    • EPSRC CDT in Aerosol Science Annual Conference 2023
    • ERS International Congress 2023
    • ISAM Congress 2023
    • RDD Europe 2023
  • Contact
  • The Aerosol Society logo
Otmar Schmid :

Otmar Schmid

Helmholtz Zentrum München

Paper: The Role of Aerosols in Preclinical Drug Development

Dr. Schmid is head of the Pulmonary Aerosol Delivery Group at the Comprehensive Pneumology Center and Helmholtz Zentrum München (Munich, Germany) and he is Adjunct Assistant Professor at the Missouri University of Science and Technology (Rolla, MO, USA).

His current research interests range from health risks to diagnostic and therapeutic opportunities of respiratory aerosol. He has developed advanced methods for dosimetry and aerosol delivery to preclinical models of the lung and he is exploring in-vitro/in-vivo correlations in toxicology, efficacy and pharmacokinetics. He has published more than 80 peer-reviewed papers and book chapters, he has served on the boards of numerous professional associations, and he has been active as consultant to pharma industry and regulatory bodies.

  • Terms
  • Privacy & Cookie policy
  • Contact
  • Committee

© 2023 Drug Delivery to the Lungs Website design: definingdesign.co.uk